Literature DB >> 21566457

Tissue-specific apoptotic effects of the p53 codon 72 polymorphism in a mouse model.

Gregory A Azzam1, Amanda K Frank, Monica Hollstein, Maureen E Murphy.   

Abstract

Currently there are several dozen human polymorphisms that have been loosely associated with cancer risk. Correlating such variants with cancer risk has been challenging, primarily due to factors such as genetic heterogeneity, contributions of diet and environmental factors, and the difficulty in obtaining large sample sizes for analysis. Such difficulties can be circumvented with the establishment of mouse models for human variants. Recently, several groups have modeled human cancer susceptibility polymorphisms in the mouse. Remarkably, in each case these mouse models have accurately reflected human phenotypes, and clarified the contribution of these variants to cancer risk. We recently reported on a mouse model for the codon 72 polymorphism in p53, and found that this polymorphism regulates the ability to cooperate with NF-kB and induce apoptosis. Here-in we present evidence that this polymorphism impacts the apoptotic function of p53 in a tissue-specific manner; such tissue-specific effects of polymorphic variants represent an added challenge to human cancer risk association studies. The data presented here support the premise that modeling human polymorphisms in the mouse represents a powerful tool to assess the impact of these variants on cancer risk, progression and therapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21566457      PMCID: PMC3117039          DOI: 10.4161/cc.10.9.15344

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  28 in total

1.  Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis.

Authors:  Jerry E Chipuk; Tomomi Kuwana; Lisa Bouchier-Hayes; Nathalie M Droin; Donald D Newmeyer; Martin Schuler; Douglas R Green
Journal:  Science       Date:  2004-02-13       Impact factor: 47.728

2.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  The codon 47 polymorphism in p53 is functionally significant.

Authors:  Xiaoxian Li; Patrick Dumont; Anthony Della Pietra; Cory Shetler; Maureen E Murphy
Journal:  J Biol Chem       Date:  2005-04-25       Impact factor: 5.157

4.  A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.

Authors:  Gareth L Bond; Wenwei Hu; Elisabeth E Bond; Harlan Robins; Stuart G Lutzker; Nicoleta C Arva; Jill Bargonetti; Frank Bartel; Helge Taubert; Peter Wuerl; Kenan Onel; Linwah Yip; Shih-Jen Hwang; Louise C Strong; Guillermina Lozano; Arnold J Levine
Journal:  Cell       Date:  2004-11-24       Impact factor: 41.582

5.  Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex.

Authors:  J I-Ju Leu; Patrick Dumont; Michael Hafey; Maureen E Murphy; Donna L George
Journal:  Nat Cell Biol       Date:  2004-04-11       Impact factor: 28.824

6.  A genetic variant BDNF polymorphism alters extinction learning in both mouse and human.

Authors:  Fatima Soliman; Charles E Glatt; Kevin G Bath; Liat Levita; Rebecca M Jones; Siobhan S Pattwell; Deqiang Jing; Nim Tottenham; Dima Amso; Leah H Somerville; Henning U Voss; Gary Glover; Douglas J Ballon; Conor Liston; Theresa Teslovich; Tracey Van Kempen; Francis S Lee; B J Casey
Journal:  Science       Date:  2010-01-14       Impact factor: 47.728

7.  p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis.

Authors:  Daniele Bergamaschi; Milena Gasco; Louise Hiller; Alexandra Sullivan; Nelofer Syed; Giuseppe Trigiante; Isik Yulug; Marco Merlano; Gianmauro Numico; Alberto Comino; Marlene Attard; Olivier Reelfs; Barry Gusterson; Alexandra K Bell; Victoria Heath; Mahvash Tavassoli; Paul J Farrell; Paul Smith; Xin Lu; Tim Crook
Journal:  Cancer Cell       Date:  2003-04       Impact factor: 31.743

8.  Polymorphisms and DNA methylation of gene TP53 associated with extra-axial brain tumors.

Authors:  L O Almeida; A C Custódio; G R Pinto; M J Santos; J R W Almeida; C A Clara; J A Rey; C Casartelli
Journal:  Genet Mol Res       Date:  2009-01-06

9.  A single nucleotide change in the mouse genome accelerates breast cancer progression.

Authors:  Nina Seitzer; Thomas Mayr; Sylvia Streit; Axel Ullrich
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

10.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

View more
  20 in total

1.  The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the Liver.

Authors:  Julia I-Ju Leu; Maureen E Murphy; Donna L George
Journal:  J Liver       Date:  2013

2.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

3.  The African-specific S47 polymorphism of p53 alters chemosensitivity.

Authors:  Subhasree Basu; Thibaut Barnoud; Che-Pei Kung; Matthew Reiss; Maureen E Murphy
Journal:  Cell Cycle       Date:  2016-08-02       Impact factor: 4.534

4.  The p53 R72P polymorphism does not affect the physiological response to ionizing radiation in a mouse model.

Authors:  Emily R Domínguez; Jennifer Orona; Kevin Lin; Carlos J Pérez; Fernando Benavides; Donna F Kusewitt; David G Johnson
Journal:  Cell Cycle       Date:  2017-06-08       Impact factor: 4.534

5.  Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes.

Authors:  G J Ortiz; Y Li; S M Post; V Pant; S Xiong; C A Larsson; A K El-Naggar; D G Johnson; G Lozano
Journal:  Oncogene       Date:  2017-09-18       Impact factor: 9.867

6.  The Codon 72 TP53 Polymorphism Contributes to TSC Tumorigenesis through the Notch-Nodal Axis.

Authors:  Jun-Hung Cho; Bhaumik Patel; Santosh Bonala; Hossein Mansouri; Sasikanth Manne; Surya Kumari Vadrevu; Shanawaz Ghouse; Che-Pei Kung; Maureen E Murphy; Aristotelis Astrinidis; Elizabeth P Henske; David J Kwiatkowski; Maciej M Markiewski; Magdalena Karbowniczek
Journal:  Mol Cancer Res       Date:  2019-05-14       Impact factor: 5.852

Review 7.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

Review 8.  Genetic Modifiers of the p53 Pathway.

Authors:  Subhasree Basu; Maureen E Murphy
Journal:  Cold Spring Harb Perspect Med       Date:  2016-04-01       Impact factor: 6.915

9.  Effects of prostaglandin E2 on p53 mRNA transcription and p53 mutagenesis during T-cell-independent human B-cell clonal expansion.

Authors:  Shabirul Haque; Xiao Jie Yan; Lisa Rosen; Steven McCormick; Nicholas Chiorazzi; Patricia K A Mongini
Journal:  FASEB J       Date:  2013-10-21       Impact factor: 5.191

Review 10.  Recent discoveries in the cycling, growing and aging of the p53 field.

Authors:  James A McCubrey; Zoya N Demidenko
Journal:  Aging (Albany NY)       Date:  2012-12       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.